Evidence · Economics · Evaluation
Building and decoding healthcare innovation — from idea to real-world impact.
I’m a pharmacist, epidemiologist, and public health specialist with an MPH in Global Epidemiology from Emory University and a Pharmacy degree from Mumbai University.
I’ve driven data-driven health solutions across the US, Australia, and India — from real-world evidence research to chronic disease strategy at the CDC.
Currently seeking roles in pharmacoepidemiology, health economics, data analysis, health strategy, and consulting — dedicated to work that advances health equity and systemic change.
Cost-effectiveness modeling, resource allocation optimization, and HTA-adjacent analyses that inform coverage and reimbursement decisions.
Federal and nonprofit program evaluations, stakeholder-driven evidence synthesis, and implementation assessments.
Observational study design, longitudinal data analysis, and population health analytics using administrative and clinical data.
Multi-country research coordination, eHealth intervention evaluation, and implementation science across diverse contexts.
Transform technical findings into executive-ready narratives that inform leadership decisions and policy directions.
Sophisticated methods should serve communication, not the reverse. The best analysis is one that decision-makers can actually use.
Evidence without clarity is just noise. Rigor in the work. Clarity in the telling.
Built strong clinical and health systems foundations, developing early interest in access, equity, and population-level impact.
Worked on cost-effectiveness, real-world evidence, and health technology assessments supporting access and portfolio decisions.
Formal training in epidemiology, biostatistics, health economics, and program evaluation with applied global and humanitarian research.
Led evaluation, performance monitoring, and data-driven decision support across prevention-focused federal programs.
Independently funded research across the United States, United Kingdom, Australia, and India.
Leading performance improvement, evaluation, and data-driven strategy for public health and community-based clients.
Designed interactive dashboards to track funding flows, performance metrics, and access indicators across federal programs.
View Sample ↗Authored stakeholder-facing evaluation and impact reports synthesizing qualitative and quantitative evidence.
View Sample ↗Led epidemiological and implementation-focused studies demonstrating strong study design and analytical rigor across multiple contexts.
View Sample ↗Developed rigorous research protocols and evidence synthesis frameworks for peer-reviewed publication.
View Sample ↗Data informs, but context and values ultimately guide choices. I help leaders see both the numbers and the nuance.
Every decision has costs. Making them visible enables more honest, equitable, and sustainable choices.
Efficacy studies tell part of the story. Understanding feasibility, adoption, and sustainability completes the picture.
Sophisticated methods serve communication, not the reverse. The best analysis is one that decision-makers can actually use.
“Shikha excels in cultural competence — a unique ability to engage with diverse communities. Her empathetic approach and commitment to inclusivity made her an essential asset to our team.”
“What truly sets Shikha apart is her eagerness to learn and continuously expand her skill set. She consistently went above and beyond — diving deeper into data analysis, refining methodologies, leveraging new tools.”
“She quickly became an invaluable team member. Her ability to grasp complex concepts quickly and contribute meaningful insights made a real impact. She took full ownership and delivered exceptional results.”
A podcast sharing real stories of healthcare builders — how they identify problems, navigate complex systems, and create solutions that drive both health and economic impact.
Open to consulting engagements, research collaborations, and applied economics roles across public health, global health, and health technology consulting.
P.S. — I’m equally comfortable skydiving and debating Harry Potter theories. Evidence-based decisions, always.